Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology , inflammatory and infectious diseases, proudly announces Dr. Tina ...

Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development ...

Kenworth and Averitt donate, ATA and WIT open nominations for scholarships and awards, and UAF releases a new award.

The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

Every successful business I've launched has had one important thing in common: They've solved a pain point. Back in college, ...

Cibc World Markets Corp bought a new position in MiMedx Group, Inc. (NASDAQ:MDXG – Free Report) in the 4th quarter, ...

Medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging.